Seattle-based Good Therapeutics designs therapies that can be administered systemically for targeted activation in the body. (Good Therapeutics Graphic) Pharmaceutical giant Roche will acquire Good Therapeutics, reeling in its lead program six years after the Seattle startup was founded to design drugs that operate only where needed in the body. Roche will make an upfront…
